Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Isopropanol | HCID 3776 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Vilazodone | HCID 6918314 | — |
| Solvent | Benzyl Alcohol | HCID 244 | — |
| Product | Benzyl Alcohol | HCID 244 | — |
| Product | 2-benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1) | HCID 6918313 | — |
Reaction Steps
1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine (2 g) was dissolved in a 1:1 mixture of benzyl alcohol:DMF (6 ml) under inert gas atmosphere 20-25° C. To the clear solution was added HCl in isopropanol (0.98 g, 1.2 eq). The resulting suspension was stirred for about 20 h at 20-25° C. The solid was filtered, washed with MTBE (2×10 ml) and dried at 65° C. to afford 1.8 g hemi solvate of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride with benzyl alcohol.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09382233B2 |
|---|
| Source dataset | uspto-grants-2016_07 |
|---|
| ORD ID | ord-0e2e0ef758cf43d48b476a2018e04b4c |
|---|
| Source note | uspto-grants-2016_07 |
|---|
